GP Stakes, Secondaries & Continuation Vehicles

Private equity is, by design, illiquid. Funds lock capital up for a decade, and value is realized only when portfolio companies are sold. But over the past decade an entire ecosystem has grown up to manufacture liquidity without waiting for those exits — liquidity for the firm, for its LPs, and for its assets. Three mechanisms dominate: GP stakes, LP secondaries, and GP-led continuation vehicles.

GP stakes: selling a piece of the firm

A GP stake is a minority equity interest in the management company itself — the business that manages the funds — not in any individual fund or portfolio company. Specialist investors (dedicated GP-stakes funds run by large alternative managers) buy these positions.

What the stake buyer gets:

• A share of the firm's management fees (a stable, recurring revenue stream).
• A share of carried interest on future funds.
• Sometimes a slice of the firm's balance-sheet investments (GP commitments).

Why a GP would sell a piece of itself:

• Founder liquidity — letting founding partners monetize decades of equity value without leaving.
• Growth capital — funding expansion into new strategies, geographies, or GP commitments to ever-larger funds.
• Succession and retention — providing capital to buy out retiring partners and re-allocate equity to the next generation.

The stake buyer is typically passive — a minority, non-control position that shares in economics without running the firm. The trade-off for the GP is giving away a permanent slice of the firm's most valuable asset: its future fee and carry streams.

LP secondaries: trading fund positions

An LP secondary is the sale of an existing limited partner's interest in a fund from one investor to another. The seller gets immediate cash and offloads remaining unfunded commitments; the buyer steps into the seller's shoes for the rest of the fund's life.

Why LPs sell:

• Portfolio management — rebalancing away from a manager, vintage, or strategy, or trimming an over-allocation to private markets (the "denominator effect," when public-market declines push private allocations over target).
• Liquidity — freeing locked-up capital without waiting for the fund to wind down.
• Reducing manager relationships — pruning a long tail of small positions.

Why buyers buy:

• Shorter duration and visibility — the portfolio is partly built, so there is less blind-pool risk and a faster path to distributions.
• Discount to NAV — secondaries often trade below reported net asset value, offering a potential return cushion.

The LP secondary market is now large, mature, and increasingly a routine portfolio-management tool rather than a distress signal.

GP-led continuation vehicles

The fastest-growing and most scrutinized structure is the GP-led secondary, most often a continuation vehicle (or continuation fund). Here the GP moves one or more assets out of an existing fund and into a new vehicle it also manages, backed by new (usually secondary) investors.

How it works:

• The GP identifies a portfolio company (or a few) it wants to keep holding — often a strong performer with more upside to run.
• A new continuation vehicle is created to buy that asset from the old fund.
• Existing LPs choose: cash out at the transaction price, or roll their interest into the new vehicle to keep participating.
• New secondary investors provide fresh capital and anchor the pricing.

Why GPs use them:

• Holding winners longer — the traditional 10-year fund life can force a sale of a still-compounding asset; a continuation vehicle resets the clock.
• Liquidity for existing LPs — those who want out get cash now.
• Fresh capital — the new vehicle can fund additional growth or bolt-ons.

Conflicts of interest — the central issue

Continuation vehicles sit on top of a structural conflict, because the GP is effectively on both sides of the transaction: it is the seller (managing the old fund, owing a duty to those LPs) and the buyer (managing the new fund). That creates unavoidable tensions:

• Pricing — the GP wants a fair (or low) price as buyer but a high price as fiduciary to the selling LPs. Who sets the price, and is it truly arm's length?
• Fee and carry reset — the GP may crystallize carry on the old fund and start a fresh fee-and-carry stream on the new one, potentially earning twice on the same asset.
• The rollover decision — LPs asked to choose between cashing out and rolling may lack the information or time to evaluate the price fairly.

Market practice has evolved to manage these conflicts:

• Independent price discovery — anchoring the deal to a competitive process among third-party secondary buyers, so the price is validated externally.
• Fairness opinions and LP advisory committee (LPAC) approval — obtaining independent valuation opinions and consent from the fund's LP advisory committee.
• "Status quo" options — giving rolling LPs the ability to keep economics broadly equivalent to what they had, rather than being forced into worse terms.
• Disclosure — clear communication of the price, the process, the conflicts, and the alternatives.

Industry bodies such as ILPA have published guidance pushing exactly these safeguards.

The bigger picture

These three tools reflect private equity's maturation into an asset class that needs internal liquidity mechanisms. GP stakes provide liquidity and capital to the firm; LP secondaries provide liquidity to investors; continuation vehicles provide liquidity to a fund while letting the GP keep its best assets. All three are legitimate and now mainstream. The recurring theme — and the thing every LP should watch — is conflict management: whenever the GP stands to benefit from a transaction it also controls, the integrity of the price and the quality of the disclosure are what separate a fair deal from a self-dealing one.